Introduction {#S1}
============

Atherosclerotic changes in coronary arteries contribute to development of cardiovascular diseases, being the leading cause of death. Coronary artery bypass grafting (CABG) surgery improves myocardial blood supply and remains one of the most frequently performed surgical procedures \[[@ref1]\].

Continuous or interval training using a cycle ergometer or treadmill is a recommended form of rehabilitation after CABG surgery, but its intensity should not exceed the anaerobic threshold \[[@ref2]\], where blood lactate concentration (BLC) reaches 4 mmol/l \[[@ref3]\]. Rehabilitation programs based on walking are an excellent alternative to the commonly used cycle ergometer training, hence there is a need for developing new ones \[[@ref4]\].

Aim {#S2}
===

The aim of this study was to apply continuous walking training as an alternative to interval cycle ergometer training in men after CABG surgery, using the 6-minute walk test (6-MWT) to determine the initial training load.

Material and methods {#S3}
====================

Study participants {#S3_1}
------------------

We recruited 44 consecutive patients aged 45 to 76 years after CABG surgery, who were admitted to the Cardiac Rehabilitation Ward of the Provincial Hospital in Poznan, Poland. This study was conducted in accordance with the amended Declaration of Helsinki. Poznan University of Medical Sciences Bioethics Committee approved the protocol (841/13) and written informed consent was obtained from all patients.

Inclusion criteria were male gender, CABG surgery performed in the last 3 months, completion of at least 12, but no more than 15, training sessions and participation in preliminary and final tests. Exclusion criteria were contraindications to the treadmill exercise stress test (TEST) \[[@ref5]\]. In order of admission to the ward patients were alternately assigned to continuous training on a treadmill (study group) or standard interval training on a cycle ergometer (control group).

Study design {#S3_2}
------------

Participants underwent a clinical assessment including TEST and 6-MWT at the begining and after completion of the rehabilitation program. All patients participated in one training session a day and 20 minutes exercises in a sitting position on a chair performed twice a day, 6 times per week.

The exercise stress test was carried out on a Full Vision Inc. treadmill (TMX425, USA), using the Welch Allyn CardioPerfect (USA) workstation and a 3-minute incremental protocol (Modified Bruce 2). The 12-lead ECG and blood pressure (BP) were continuously obtained. The end point was assessed according to criteria of the American Heart Association \[[@ref5]\] or reaching 15 points in the 20-grade Borg Scale. During the recovery phase, participants were advised to continue walking with a speed of 2.0 km/h and a slope of 0% for 1 minute, while in the 3^rd^ and 4^th^ minute patients were sitting. Oxygen uptake (VO~2~) was estimated using METs \[[@ref6]\], and maximum heart rate (HR~max~) was calculated based on the equation HR~max~ = 220 -- age.

The 6-MWT was conducted in accordance with the American Thoracic Society guidelines \[[@ref7]\], on a 25 m long corridor. HR and BP were measured before and after the test. Predicted walking distance \[[@ref8], [@ref9]\] and VO~2~ \[[@ref10]\] were estimated using an equation. Energy expenditure (MET) was determined by dividing the VO~2~ value by 3.5 \[[@ref6]\]. The 20-grade Borg Scale for rating perceived exertion was used.

The basis for determining the individual initial training load for patients from the study group was the result of the 6-MWT. Predicted peak VO~2~ was calculated using the equation \[[@ref10]\]:

Peak VO~2~ = 0.02 × distance (m) -- 0.191 × age (years) -- 0.07 × weight (kg) + 0.09 × height (cm) + 0.26 × DP × 0.001 + 2.45.

Distances at 50%, 60% and 70% of peak VO~2~ were estimated, assuming respectively 50%, 60% and 70% of baseline peak VO~2~ and double product (DP) values. Age, body weight and height were constant. Values of predicted distances at 50%, 60% and 70% of peak VO~2~ allowed initial speeds of walking to be determined by dividing distance values by 100. Depending on general condition -- the patient started walking on a flat treadmill (Kettler Track Experience, Germany) with estimated speed of 50%, 60% or 70% of peak VO~2~.

The first session lasted 10 minutes, and the next ones were gradually extended to 20 minutes. Walking speed was increased individually depending on the patient's general condition every 2--5 sessions by 0.2--0.5 km/h. Maximum speed was limited by the value at which the participant made a switch from walking to running.

The basis for determining the individual initial training load for patients from the control group was a result of TEST. Depending on general condition, the patient was given a maximum initial load of 50% to 70% of METs that were converted into watts \[[@ref11]\].

A single training session lasted approximately 20 minutes and consisted of 6 to 11 intervals of increasing the load to half of training duration and decreasing until its completion. Load intervals lasted 0.5--1 minutes and were separated by 1 minute active recovery (no load pedaling). Each session started and ended with 1 minute active recovery. Subjects were asked to maintain cycling speed of 60--70 rpm.

The ECG, HR and BP were obtained during all sessions. The 20-grade Borg Scale for rating perceived exertion was used. Energy expenditure in METs \[[@ref6]\] and caloric expenditure \[[@ref11]\] were estimated individually for each walking training session and cycle ergometer training session \[[@ref12]\].

Capillary blood arterialized by rubbing the fingertip was collected around the 6^th^ and 12^th^ sessions, before and 3 minutes after training. BLC was determined using the enzymatic spectrophotometric method \[[@ref13]\]. Absorbance values were read on the Synergy 2 SIAFRT Multi-Mode Microplate Reader (BioTek Instruments, USA) at a wavelength of 340 nm.

Statistical analysis {#S3_3}
--------------------

The Shapiro-Wilk test was used to check normality of distribution. Student's *t*-test, the Mann-Whitney test, the Wilcoxon signed rank test, the χ^2^ test or Fisher's exact test was used to compare variables. Friedman's ANOVA and a post-hoc test were used to analyze repeated measures. Values of *p* \< 0.05 were considered statistically significant. Statistica version 13.1 software (Dell Inc., USA) was used for statistical analysis.

Results {#S4}
=======

Participant characteristics {#S4_1}
---------------------------

Forty-one patients completed rehabilitation programs. Three patients were excluded from the study due to: (1) complaints related to abdominal aortic and iliac aneurysms, (2) bacterial infection of the respiratory tract, (3) discharge at request. The first 2 patients received an individual rehabilitation program. Baseline characteristics of both groups are shown in [Table I](#T1){ref-type="table"}.

###### 

Baseline characteristics

  -----------------------------------------------------------------------------------------------------------------------
  Variable                                    Study\                                    Control\     *P*-value    
                                              group\                                    group\                    
                                              (*n* = 20)                                (*n* = 21)                
  ------------------------------------------- ----------------------------------------- ------------ ------------ -------
  Demographics, mean (SD):                                                                                        

                                              Age \[years\]                             63 (6)       61 (7)       NS

                                              BMI \[kg/m2\]                             28.7 (4.3)   29.9 (5.1)   NS

                                              Waist circumference \[cm\]                103 (12)     103 (12)     NS

  Prior surgical revascularization, *n* (%)   5 (25)                                    6 (29)       NS           

  Comorbidities, *n* (%):                                                                                         

                                              Chronic ischemic heart disease            20 (100)     21 (100)     NS

                                              Hypertension                              18 (90)      19 (90)      NS

                                              Type 2 diabetes                           4 (20)       7 (33)       NS

                                              Other carbohydrate metabolism disorders   4 (20)       3 (14)       NS

                                              Lipid metabolism disorders                14 (70)      18 (86)      NS

                                              Prior myocardial infarction               8 (40)       17 (81)      0.007

  Surgical technique:                                                                                             

                                              CABG                                      15 (75)      15 (71)      NS

                                              OPCAB                                     4 (20)       6 (29)       NS

                                              MIDCAB                                    1 (5)        --           NS

  Number of grafts, *n* (%):                                                                                      

                                              1                                         3 (15)       1 (5)        NS

                                              2                                         2 (10)       7 (33)       NS

                                              3                                         13 (65)      10 (48)      NS

                                              4                                         2 (10)       3 (14)       NS

  Postoperative medication, *n* (%):                                                                              

                                              Statins                                   20 (100)     21 (100)     NS

                                              Beta-blockers                             20 (100)     21 (100)     NS

                                              Aspirin                                   20 (100)     21 (100)     NS

                                              Sulfonamides                              18 (90)      18 (86)      NS

                                              Potassium                                 17 (85)      15 (71)      NS

                                              PPIs                                      14 (70)      16 (76)      NS

                                              ACE inhibitors                            13 (65)      12 (57)      NS

                                              Aldosterone antagonists                   12 (60)      6 (29)       0.04

                                              Ivabradine                                4 (20)       4 (19)       NS

                                              ARBs                                      3 (15)       3 (14)       NS

                                              CCBs                                      2 (10)       5 (24)       NS

  LVEF, %, mean (SD)                          52 (7)                                    52 (7)       NS           

  Pericardial effusion, *n* (%)               7 (35)                                    7 (33)       NS           
  -----------------------------------------------------------------------------------------------------------------------

ACE -- angiotensin-converting enzyme, ARBs -- angiotensin II receptor blockers, BMI -- body mass index, CABG -- coronary artery bypass grafting, CCBs -- calcium channel blockers, LVEF -- left ventricular ejection fraction, MIDCAB -- minimally invasive direct coronary artery bypass, OPCAB -- off-pump coronary artery bypass, PPIs -- proton pump inhibitors.

Treadmill exercise stress tests {#S4_2}
-------------------------------

There were no differences between groups at baseline, except for HR recovery in 1 minute that was faster in the control group (*p* = 0.002). After interventions significant changes in METs, VO~2,~ duration, peak HR, percentage of peak HR in relation to HR~max~, HR reserve, and HR recovery at 3 and 4 minutes were observed in both groups. Statistically significant improvements after intervention in systolic blood pressure (SBP), HR and DP at peak exercise load in the baseline test, resting HR, HR recovery in 1 minute and resting DP (on the borderline of significance) were seen only in the study group ([Table II](#T2){ref-type="table"}). No statistically significant differences were found between groups in the final test.

###### 

Comparison of baseline and post-intervention outcomes of treadmill exercise stress tests in both groups

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                                    Study group (*n* = 20)   Control group (*n* = 21)                                                   
  ------------------------------------------- ------------------------ -------------------------- ------------- ---------------- ---------------- ----------
  METs                                        4.4 (1.4)                6.3 (1.3)                  \< 0.001      5.0 (1.4)        6.5 (1.4)        \< 0.001

  Oxygen uptake \[ml/kg/min\]                 15.4 (4.9)               22.1 (4.6)                 \< 0.001      17.5 (4.9)       22.8 (4.9)       \< 0.001

  Duration \[min\]                            6 (2)                    8 (2)                      \< 0.001      7 (2)            8 (2)            \< 0.001

  RPE                                         14 (1)                   14 (1)                     NS            15 (1)           15 (1)           NS

  Rest SBP \[mm Hg\]                          113 (14)                 113 (12)                   NS            111 (13)         111 (14)         NS

  SBP at peak exercise load in baseline\      162 (21)                 145 (24)                   \< 0.001      153 (14)         153 (19)         NS
  test \[mm Hg\]                                                                                                                                  

  Peak SBP \[mm Hg\]                          162 (21)                 163 (25)                   NS            153 (14)         164 (21)         0.005

  Rest DBP \[mm Hg\]                          71 (8)                   70 (7)                     NS            68 (8)           68 (8)           NS

  Peak DBP \[mm Hg\]                          87 (6)                   86 (9)                     NS            84 (5)           87 (7)           0.03

  Rest HR \[mm Hg\]                           86 (6)                   79 (9)                     0.004         82 (14)          77 (14)          NS

  Peak HR \[mm Hg\]                           113 (11)                 120 (14)                   0.03          113 (17)         118 (18)         0.005

  HR at peak exercise load in baseline\       113 (11)                 104 (15)                   \< 0.001      113 (17)         109 (21)         NS
  test \[bpm\]                                                                                                                                    

  Peak HR -- % of HR~max~                     73 (8)                   76 (9)                     0.04          72 (12)          75 (13)          0.01

  HR reserve \[bpm\]                          28 (10)                  41 (10)                    \< 0.001      31 (15)          41 (13)          \< 0.001

  HR recovery at 1 min \[bpm\]                7 (4)                    17 (14)                    \< 0.001      12 (5)           14 (6)           NS

  HR recovery at 3 min \[bpm\]                29 (8)                   40 (14)                    \< 0.001      32 (12)          37 (10)          0.003

  HR recovery at 4 min \[bpm\]                29 (7)                   40 (14)                    \< 0.001      32 (12)          39 (12)          \< 0.001

  Rest DP                                     9 710 (1 215)            8 972 (1 315)              NS (0.0505)   9 095 (1 606)    8 559 (1 769)    NS

  Peak DP                                     18 469 (3 619)           19 620 (4 042)             NS            17 223 (2 827)   19 418 (3 800)   0.001

  DP at peak exercise load in baseline test   18 469 (3 619)           15 151 (4 364)             \< 0.001      17 223 (2 827)   16 746 (3 858)   NS
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as mean (SD). DBP -- diastolic blood pressure, DP -- double product, HR -- heart rate, MET -- metabolic equivalent, RPE -- rating of perceived exertion, SBP -- systolic blood pressure.

Six-minute walk tests {#S4_3}
---------------------

No differences were found between groups at baseline and after rehabilitation. A significant increase in walking distance, mean walking speed, percentage of predicted walking distance and HR reserve were observed in both cohorts ([Table III](#T3){ref-type="table"}). Mean increment of walking distance was 99 (55) m (*p* \< 0.001), which was 27% (26) (*p* \< 0.001) of baseline distance in the study group. These values were lower in the control group at 72 (43) m (*p* \< 0.001) and 17% (11) (*p* \< 0.001), respectively. Significant reduction in resting HR and DP after intervention was noted only in the study group. Energy expenditure and VO~2~ increased in the final test in both cohorts.

###### 

Comparison of baseline and after intervention outcomes of six-minute walk tests in both groups

  Variable                      Study group (*n* = 20)   Control group (*n* = 21)                                                
  ----------------------------- ------------------------ -------------------------- ---------- ---------------- ---------------- ----------
  Distance \[m\]                420 (80)                 519 (61)                   \< 0.001   438 (58)         510 (63)         \< 0.001
  Speed \[km/h\]                4.2 (0.8)                5.2 (0.6)                  \< 0.001   4.4 (0.6)        5.1 (0.6)        \< 0.001
  Distance -- % predicted       70 (14)                  86 (11)                    \< 0.001   73 (11)          84 (12)          \< 0.001
  METs                          3.3 (0.6)                3.8 (0.5)                  \< 0.001   3.4 (0.6)        3.9 (0.7)        \< 0.001
  Oxygen uptake \[ml/kg/min\]   11.4 (2.3)               13.5 (1.9)                 \< 0.001   11.7 (2.2)       13.5 (2.4)       \< 0.001
  RPE                           12 (2)                   11 (2)                     NS         12 (2)           12 (2)           NS
  Rest SBP \[mm Hg\]            115 (16)                 113 (14)                   NS         112 (10)         115 (10)         NS
  Peak SBP \[mm Hg\]            128 (17)                 129 (16)                   NS         125 (11)         133 (12)         0.007
  Rest DBP \[mm Hg\]            66 (9)                   64 (8)                     NS         62 (7)           62 (8)           NS
  Peak DBP \[mm Hg\]            69 (9)                   68 (7)                     NS         65 (8)           67 (9)           NS
  Rest HR \[bpm\]               76 (10)                  72 (8)                     0.03       73 (10)          72 (11)          NS
  Peak HR \[bpm\]               96 (10)                  97 (10)                    NS         93 (13)          97 (14)          NS
  Peak HR -- % of HR~max~       64 (7)                   64 (7)                     NS         61 (9)           64 (10)          NS
  HR reserve \[bpm\]            20 (8)                   25 (7)                     0.03       19 (8)           25 (10)          0.003
  Rest DP                       8 711 (1 151)            8 160 (1 123)              0.03       8 201 (1 244)    8 289 (1 684)    NS
  Peak DP                       12 295 (1 877)           12 533 (2 154)             NS         11 625 (2 080)   12 923 (2 544)   NS

Data are presented as mean (SD). DBP -- diastolic blood pressure, DP -- double product, HR -- heart rate, MET -- metabolic equivalent, RPE -- rating of perceived exertion, SBP -- systolic blood pressure.

Training programs {#S4_4}
-----------------

Statistical analysis showed homogeneity of both groups in terms of mean values of all studied parameters ([Table IV](#T4){ref-type="table"}).

###### 

Mean values of studied training parameters

  ---------------------------------------------------------------------------
  Variable                       Study group\    Control group\   *P*-value
                                 (*n* = 20)      (*n* = 21)       
  ------------------------------ --------------- ---------------- -----------
  Duration \[min\]               17 (2)          17 (2)           NS

  Rest SBP \[mm Hg\]             115 (11)        116 (10)         NS

  Peak SBP \[mm Hg\]             122 (12)        123 (11)         NS

  Rest DBP \[mm Hg\]             65 (6)          66 (4)           NS

  Peak DBP \[mm Hg\]             68 (7)          70 (5)           NS

  Rest HR \[bpm\]                77 (7)          75 (8)           NS

  Peak HR \[bpm\]                91 (8)          88 (11)          NS

  Rest DP                        8 874 (1074)    8 634 (972)      NS

  Peak DP                        11 163 (1673)   10 805 (1428)    NS

  RPE                            10 (2)          10 (1)           NS

  Energy expenditure \[MET\]     2.6 (0.3)       2.8 (0.3)        NS

  Caloric expenditure \[kcal\]   68 (17)         66 (14)          NS
  ---------------------------------------------------------------------------

Data are presented as mean (SD). DBP -- diastolic blood pressure, DP -- double product, HR -- heart rate, MET -- metabolic equivalent, RPE -- rating of perceived exertion, SBP -- systolic blood pressure.

We noted a statistically significant gradual increase in mean duration of training from session 3 (16.1 (4.5) minutes, *p* \< 0.05), mean treadmill walking speed from session 7 (3.1 (0.6) km/h, *p* \< 0.05), mean energy expenditure from session 7 (2.6 (0.3) MET, *p* \< 0.05), and mean caloric expenditure from session 5 (66 (21) kcal, *p* \< 0.05) in the study group. In the control group we observed a significant increase in mean energy and caloric expenditure from session 6 that amounted to 2.8 (0.3) MET (*p* \< 0.05) and 66 (15) kcal (*p* \< 0.05), respectively.

There were no differences between groups referring to BLC at rest and after exertion either in session 6 or 12. BLC did not increase significantly after exertion ([Table V](#T5){ref-type="table"}).

###### 

Blood lactate concentrations (mmol/l) during training

  Session   Study group (*n* = 20)   Control group (*n* = 21)                                
  --------- ------------------------ -------------------------- ---- ----------- ----------- ----
  6         1.7 (0.6)                2.0 (0.9)                  NS   1.9 (0.6)   2.0 (0.5)   NS
  12        1.7 (0.5)                1.8 (0.5)                  NS   1.8 (0.5)   2.0 (0.6)   NS

Data are presented as mean (SD).

No serious arrhythmias were noted during training sessions and no other adverse events were reported while exercising in either group.

Discussion {#S5}
==========

This study presents a model of low intensity walking training as an alternative to the commonly used cycle ergometer training in men after CABG surgery. According to the literature peak VO~2~ is a strong predictor of mortality in patients with coronary artery disease. A study by Kavanagh *et al*. \[[@ref14]\] showed that values of 15 to 22 ml/kg/min (4.3 to 6.3 METs) and above 22 ml/kg/min (6.3 METs) yielded, respectively, a 38% and 61% reduction in risk of cardiac death over the follow-up period. We speculate that an average 35% increase in VO~2~ may indicate a reduction in risk of death in examined patients. This outcome falls within the range of results (10.5% to 48.2%, corresponding to 1.9 to 6.6 ml/kg/min) obtained in 17 other studies involving patients after CABG surgery \[[@ref15]\].

Various factors may have affected the final outcome of cardiac rehabilitation, such as age, body mass index (BMI), comorbidities, initial level of physical capacity, commencement and duration of the rehabilitation program, type of exercise training, prescribed medications and low level of physical activity prior rehabilitation \[[@ref16]--[@ref19]\]. It should be noted that most of our patients had previous myocardial infarction (MI), and MET values underestimate the exercise intensity in post-MI men during the modified Bruce treadmill walking test. Patients exceed the anaerobic threshold faster with a lower rating of perceived exertion \[[@ref20]\].

The reduction in SBP at peak exercise load in the baseline test that we observed in the final TEST may indicate a better BP response to exertion in the study group. The proposed form of walking training probably increased the efficiency of myocardial work by the heart muscle performing less work at the same load on the body with physical effort \[[@ref21]\]. More frequent intake of aldosterone antagonists in the study group probably did not affect peak BP in control tests. The study conducted by Kosmala *et al*. \[[@ref22]\] confirmed only a reducing effect of the drug on resting BP.

In final tests we observed a decrease in resting HR and HR at peak exercise load in the baseline test only in the study group. This may indicate a beneficial effect of walking training on improvement of exercise tolerance caused by post-exercise reactivation of vagus nerve tension \[[@ref23]--[@ref25]\]. In addition, the lack of significant decrease in resting HR in the control group may result from the significantly more frequent occurrence of previous myocardial infarction in this group (40% vs. 81%). As a consequence of myocardial infarction, the sympathetic-parasympathetic balance becomes impaired, which may be manifested by elevated resting HR that reflects greater neurohormonal activation \[[@ref26]\]. It should be borne in mind, however, that mean LVEF was the same in both groups at 52%.

The increase in peak HR and percentage of HR~max~ that we found in both groups in final tests indicates a normal response of the cardiovascular and the nervous systems to physical effort \[[@ref25]\]. We also observed an increase in HR reserve, which can be an indicator of progression of physical exercise load on the cardiovascular system \[[@ref27]\].

In the final TEST, HR reserve increased from 40% (15) to 54% (17) (*p* \< 0.001) in the study group, and from 41% (23) to 53% (22) (*p* \< 0.001) in the control group. We defined impaired HR reserve as below 62% because all patients were treated with β-blockers \[[@ref28], [@ref29]\]. Our data suggest that this chronotropic incompetence may be associated with an increased risk of major adverse cardiac events \[[@ref28]\], but it can be assumed that continuation of regular physical activity will contribute to a further increase in HR reserve. An imbalance between sympathetic and parasympathetic components of the autonomic nervous system may limit HR reserve during exercise \[[@ref26]\]. Other studies suggest that an impaired HR reserve protects the myocardium from high HR values and associated demand for coronary blood flow \[[@ref30]\].

Studies indicate a strong relationship between slower HR recovery and insufficient perfusion of the myocardium \[[@ref31]--[@ref34]\]. In the final TEST we observed faster HR recovery in 3 and 4 minutes in both groups and in 1 minute only in the study group. Final outcomes may indicate similar therapeutic effectiveness of both types of training that was manifested by acceleration of HR recovery in 1 minute to values above 12 bpm, which are normal \[[@ref21], [@ref35]\]. This could be due to increased activity of the parasympathetic nervous system following physical activity \[[@ref21]\]. Similar results were obtained by authors of other studies \[[@ref36]--[@ref38]\].

According to the literature, DP is a good indicator of myocardial workload and is often used in clinical practice \[[@ref39], [@ref40]\], but β-blocker intake may significantly reduce its value \[[@ref41]\]. Our final results indicate a myocardial oxygen demand reduction at rest in the study group \[[@ref39], [@ref42], [@ref43]\]. Exercise DP remained at a similar level in both groups, therefore myocardial workload and demand for oxygen were similar, as in the Moradi *et al*. \[[@ref40]\] research. Exercise DP at peak exercise load in the baseline test decreased only in the study group. Probably, as a result of applied walking training, we observed an improvement in physical exercise tolerance expressed in decrease in myocardial oxygen demand during constant load \[[@ref39]--[@ref43]\].

We noted an increase in walking distance by 99 (55) m (27% (26)) in the study group and by 72 (43) m (17% (11)) in the control group. According to Fiorina *et al*. \[[@ref44]\], an increase in walking distance above 10% indicates a significant improvement in the patient's exercise tolerance and functional status. Walking distance of 300 m \[[@ref45]--[@ref47]\] or 350 m \[[@ref48]\] is the value above which the patient's prognosis becomes good, and therefore average results of our participants should be considered clinically beneficial.

We did not observe changes in HR, BP and DP during training sessions, probably due to too short duration of rehabilitation programs. Average rating of perceived exertion during training was 10 and it corresponds to low-intensity training below 3 METs and 20% to 40% of HR reserve. This degree of intensity is particularly important at an early stage of rehabilitation after CABG surgery, because most basic activities of everyday life are carried out at this level of intensity \[[@ref49]\].

All patients also participated twice a day in full-body exercises during which they spent about 60 kcal per session \[[@ref50]\]. It resulted in an average expenditure of approximately 190 kcal/day during supervised activities, which is consistent with recommendations \[[@ref51]\].

Measurement of BLC allows optimization of the effectiveness of rehabilitation programs, determining their structure and maximizing health benefits while minimizing the risk of adverse events \[[@ref52]\]. Mean resting BLC in both groups was within the normal range (0.6--2.0 mmol/l) developed by the laboratory where analyses were carried out. Resting BLC remained unchanged regardless of physical training. Mean levels of lactate after exercise ≤ 2.0 mmol/l indicated the aerobic form of proposed training \[[@ref3]\]. We noted that BLC after the 6^th^ and 12^th^ training session remained at a similar level despite an increase in their intensity. This may suggest an improvement in physical exercise tolerance expressed by more efficient utilization of lactate \[[@ref53]\].

Although our results have application value for cardiac rehabilitation, our study also has limitations. First, the sample size was small (*n* = 41), due to occurrence of exclusion criteria in a significant number of patients. Second, we did not include women in our study, because men undergo CABG surgery 4--5 times more often than women \[[@ref54]\]. Participation of women in a small sample could significantly affect the results of our study.

Conclusions {#S6}
===========

The proposed model of low intensity walking training is of similar effectiveness to cycle ergometer training in improving exercise tolerance in men at an early stage of rehabilitation after coronary artery bypass surgery and can be used alternatively. The initial training load in walking training in men after coronary artery bypass surgery can be determined based on a 6-minute walk test. Intensity of both training programs in men at an early stage of rehabilitation after coronary artery bypass surgery does not lead to exceeding the anaerobic threshold.
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